92 related articles for article (PubMed ID: 11285642)
1. [The effect of a high dose bovine herpes virus 1 marker vaccine in pregnant heifers: virological, bacteriological, immunological, and pathological findings].
Bruschke CJ; Kamp EM; Boersma W; Stockhofe-Zurwieden N; Bouma A
Tijdschr Diergeneeskd; 2001 Mar; 126(6):211-7. PubMed ID: 11285642
[TBL] [Abstract][Full Text] [Related]
2. [Analysis of symptoms associated with bovine herpesvirus 1 vaccination].
van Wuijckhuise L; Frankena K; van Oijen MA; Meijer L
Tijdschr Diergeneeskd; 2001 Mar; 126(6):173-80. PubMed ID: 11285635
[TBL] [Abstract][Full Text] [Related]
3. [Vaccination of calves with contaminated batches of bovine herpes virus 1 vaccines did not result in infection with bovine virus diarrhea virus].
Antonis AF; van Oirschot JT; van Es M; Bruschke CJ
Tijdschr Diergeneeskd; 2001 Mar; 126(6):208-11. PubMed ID: 11285641
[TBL] [Abstract][Full Text] [Related]
4. [Comparison of performance of dairy herds that were or were not vaccinated with a bovine herpes virus 1 marker vaccine in 1998].
Bartels CJ; Barkema HW; Beiboer ML; Bouma A; Stegeman JA
Tijdschr Diergeneeskd; 2001 Mar; 126(6):191-7. PubMed ID: 11285639
[TBL] [Abstract][Full Text] [Related]
5. [Did vaccination with an infectious bovine rhinotracheitis (IBR) marker vaccine on thirteen cattle farms give rise to chronic wasting among dairy cattle?].
de Kruif A
Tijdschr Diergeneeskd; 2001 Mar; 126(6):166-73. PubMed ID: 11285634
[TBL] [Abstract][Full Text] [Related]
6. [Possibilities for further research of chronic wasting in dairy cows].
Meijer GA; Bouma A; Verhoeff J
Tijdschr Diergeneeskd; 2001 Mar; 126(6):223-5. PubMed ID: 11285644
[TBL] [Abstract][Full Text] [Related]
7. [Management and herd performance of dairy herds with and without chronic wasting disease].
Bartels CJ; Barkema HW; Beiboer ML; Bouma A; Stegeman JA
Tijdschr Diergeneeskd; 2001 Mar; 126(6):198-207. PubMed ID: 11285640
[TBL] [Abstract][Full Text] [Related]
8. [Outbreak of bovine virus diarrhea on Dutch dairy farms induced by a bovine herpesvirus 1 marker vaccine contaminated with bovine virus diarrhea virus type 2].
Barkema HW; Bartels CJ; van Wuijckhuise L; Hesselink JW; Holzhauer M; Weber MF; Franken P; Kock PA; Bruschke CJ; Zimmer GM
Tijdschr Diergeneeskd; 2001 Mar; 126(6):158-65. PubMed ID: 11285633
[TBL] [Abstract][Full Text] [Related]
9. Safety of a modified-live combination vaccine against respiratory and reproductive diseases in pregnant cows.
Ellsworth MA; Brown MJ; Fergen BJ; Ficken MD; Tucker CM; Bierman P; TerHune TN
Vet Ther; 2003; 4(2):120-7. PubMed ID: 14506587
[TBL] [Abstract][Full Text] [Related]
10. Necrotic oophoritis in heifers vaccinated intravenously with infectious bovine rhinotracheitis virus vaccine during estrus.
Smith PC; Nusbaum KE; Kwapien RP; Stringfellow DA; Driggers K
Am J Vet Res; 1990 Jul; 51(7):969-72. PubMed ID: 2167621
[TBL] [Abstract][Full Text] [Related]
11. Comparison of the sensitivity of in vitro and in vivo tests for detection of the presence of a bovine viral diarrhoea virus type 1 strain.
Antonis AF; Bouma A; de Bree J; de Jong MC
Vet Microbiol; 2004 Sep; 102(3-4):131-40. PubMed ID: 15327789
[TBL] [Abstract][Full Text] [Related]
12. Effects of modified-live bovine viral diarrhea virus vaccines containing either type 1 or types 1 and 2 BVDV on heifers and their offspring after challenge with noncytopathic type 2 BVDV during gestation.
Ficken MD; Ellsworth MA; Tucker CM; Cortese VS
J Am Vet Med Assoc; 2006 May; 228(10):1559-64. PubMed ID: 16677126
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of bovine herpesvirus-1 inactivated vaccine against abortion and stillbirth in pregnant heifers.
Zimmerman AD; Buterbaugh RE; Herbert JM; Hass JM; Frank NE; Luempert Iii LG; Chase CC
J Am Vet Med Assoc; 2007 Nov; 231(9):1386-9. PubMed ID: 17976001
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of the efficacy of a modified-live combination vaccine against abortion caused by virulent bovine herpesvirus type 1 in a one-year duration-of-immunity study.
Ficken MD; Ellsworth MA; Tucker CM
Vet Ther; 2006; 7(3):275-82. PubMed ID: 17039450
[TBL] [Abstract][Full Text] [Related]
15. A live bovine herpesvirus-1 marker vaccine is not shed after intramuscular vaccination.
Makoschey B; Beer M
Berl Munch Tierarztl Wochenschr; 2007; 120(11-12):480-2. PubMed ID: 18085158
[TBL] [Abstract][Full Text] [Related]
16. Comparison of bovine herpesvirus 1 vaccines for rapid induction of immunity.
Roth JA; Carter DP
Vet Ther; 2000; 1(4):220-8. PubMed ID: 19757568
[TBL] [Abstract][Full Text] [Related]
17. Compatibility of a live infectious bovine rhinotraheitis (IBR) marker vaccine and an inactivated bovine viral diarrhoea virus (BVDV) vaccine.
Alvarez M; Bielsa JM; Santos L; Makoschey B
Vaccine; 2007 Sep; 25(36):6613-7. PubMed ID: 17669560
[TBL] [Abstract][Full Text] [Related]
18. Fetal protection against continual exposure to bovine viral diarrhea virus following administration of a vaccine containing an inactivated bovine viral diarrhea virus fraction to cattle.
Grooms DL; Bolin SR; Coe PH; Borges RJ; Coutu CE
Am J Vet Res; 2007 Dec; 68(12):1417-22. PubMed ID: 18052749
[TBL] [Abstract][Full Text] [Related]
19. Vaccination with a gE-negative bovine herpesvirus type 1 vaccine confers insufficient protection to a bovine herpesvirus type 5 challenge.
Silva AD; Spilki FR; Franco AC; Esteves PA; Hübner SO; Driemeier D; Oliveira AP; Rijsewijk F; Roehe PM
Vaccine; 2006 Apr; 24(16):3313-20. PubMed ID: 16480790
[TBL] [Abstract][Full Text] [Related]
20. Experimental trial in heifers vaccinated with Staphylococcus aureus avirulent mutant against bovine mastitis.
Pellegrino M; Giraudo J; Raspanti C; Nagel R; Odierno L; Primo V; Bogni C
Vet Microbiol; 2008 Feb; 127(1-2):186-90. PubMed ID: 17869031
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
